SAHPRA

The substandard products referenced in this alert are unsafe and their use, especially in children, may result in serious injury or death.

In SAHPRA's continuing fight against Covid-19, a new Chinese vaccine has been approved - but only under certain conditions.

SA health regulator, Sahpra has also approved the mixing and matching of the Johnson & Johnson vaccine with the Pfizer vaccine.

After initially being approved in March 2021, Pfizer has officially received the green light from SAHPRA to administer a third vaccine dose.

SAHPRA will commence with assessing the data regarding the safety and efficacy of the third Pfizer dose against Covid-19.

In relation to a new global vaccine trial for children and adolescents, SAPHRA has approved the Pfizer vaccine for children age 12 and up.

Ivermectin has become one of the most popular remedies for Covid-19 patients, however SAHPRA does not approve.